Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
39.60
+0.40 (1.02%)
Nov 21, 2024, 12:54 PM EST - Market open
Veracyte Employees
Veracyte had 815 employees as of December 31, 2023. The number of employees increased by 28 or 3.56% compared to the previous year.
Employees
815
Change (1Y)
28
Growth (1Y)
3.56%
Revenue / Employee
$521,879
Profits / Employee
-$11,372
Market Cap
3.07B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Surgery Partners | 13,500 |
Warby Parker | 3,473 |
LivaNova | 2,900 |
HUTCHMED (China) | 1,988 |
ACADIA Pharmaceuticals | 598 |
Amicus Therapeutics | 517 |
Xenon Pharmaceuticals | 259 |
Kymera Therapeutics | 187 |
VCYT News
- 14 days ago - Veracyte, Inc. (VCYT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Veracyte Announces Third Quarter 2024 Financial Results - Business Wire
- 21 days ago - Veracyte to Participate in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 - Business Wire
- 2 months ago - New Data Presented at ESMO 2024 Show that Veracyte's Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer - Business Wire
- 2 months ago - Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors - Business Wire
- 3 months ago - Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - Business Wire
- 3 months ago - Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle - Business Wire